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Abstract
Purpose: Serrated/hyperplastic polyps (SPs) are characterised histologically by sawtooth architecture. Historically, 
these polyps were considered benign, without malignant potential and thus clinically unimportant. At present, the 
WHO defines serrated/hyperplastic lesions as heterogeneous group, which include hyperplastic polyps (HP), sessile 
serrated adenoma (SSA)/polyp and traditional serrated adenoma (TSA). These can have malignant potential. The aim 
of this study was to evaluate the prevalence of dysplastic changes in SP of colon and rectum of Omani population 
reported at a tertiary care centre. 
Methods: The study was conducted in the pathology department of a tertiary care centre including endoscopic 
polypectomies from colon and rectum of Omani patients presenting to gastroenterology clinic reported between 2014 
and 2016, and these were analysed retrospectively for dysplastic changes and their association with different clinical 
parameters. 
Results: Dysplasia was seen in 32 of 146 cases (21.9%) and 114 (78.1%) were without dysplasia. Of these dysplastic, 
biopsies’ only two cases (1.4%) showed high-grade dysplasia and rest 30 (20.5%) low-grade dysplasia. According 
to the type of polyp, dysplasia was found in TSA 8/21 cases (46.7%) and SSA 9/17 cases (53.3%). Association of 
dysplasia was more common in the age group of > 50 (15.07%) and male patients (62.5%).
Conclusion: SPs are now common findings that a gastroenterologist faces in their daily practice. In our study of Omani 
population, the prevalence of dysplasia is associated with older age group, male gender, SSA/polyp and traditional 
serrated adenoma.
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Introduction
Polyp is a histological term that describes any circumscribed 
growth that projects above the surrounding mucosa. The 
term polyp itself has no ominous clinical significance. 
Polyp can be neoplastic, inflammatory or hamartomatous. 
Only histological examination can reveal their true 
identity, we can appreciate their clinical behaviour.[1]
In general, intestinal polyps are classified as non-
neoplastic or neoplastic. Most common neoplastic polyps 
are adenomas or adenomatous polyps, which arise due to 
dysplastic proliferation and have a potency to progress to 
cancer. The other types of polyps include hamartomatous, 
inflammatory and serrated/hyperplastic polyps (SPs).[1]
SPs are those characterised by sawtooth architecture from 
which it got its name. Historically, these polyps were 
considered benign, without malignant potential and thus 
clinically unimportant.[2] At present, the WHO defines 
serrated/hyperplastic lesions as heterogeneous group, 
which include hyperplastic polyps (HPs), sessile serrated 
adenoma (SSA)/polyp and traditional serrated adenoma 
(TSA).[3] These can have malignant potential.[3]
HPs are the most common type of SPs accounting 
for >75% of all serrated polyps.[4] Typically seen more 
in the left colon and, in particular, sigmoid and rectum, 
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especially in the sixth and seven decades[5] with no 
difference in occurrence between males and females.[6] 
SSPs are distinguished from HPs by crypt distortion, 
anchor-shaped or boot-shaped crypts, shown in Figure 1. 
TSAs lined by hypereosinophilic or pencillate cells.[7] 
They represent a hybrid of serrated and conventional 
adenomas [Figure 2].
It is postulated that sessile serrated polyp pathway 
starts with a mutation in BRAF oncogene; this mutation 
promotes cellular proliferation and downregulation of 
apoptosis pathway.[8]
The aim of this study was to evaluate the degree of 
dysplastic changes in SPs of colon and rectum of Omani 
population reported at a tertiary care centre in Oman.
Materials and Methods
This is a retrospective study. Ethical approval for this 
study was obtained.
Blocks and slides of tissue taken by colonoscopy of 
patients presenting to the gastroenterology clinic over a 
3-year period were retrieved through hospital information 
system. These were reevaluated for dysplasia by two 
pathologists.
All polyps reported as hyperplastic/serrated over a period 
of 2014–2016 were included in the study regardless 
of their age or gender. Polyps from other sites in the 
gastrointestinal tract and non-serrated lesion including 
adenomatous polyps and inflammatory polyps regardless 
for their site were excluded from this study.
Clinical parameters which were taken into account were 
age and sex of the patient, and age and site of polyp. The 
patients were grouped into three age groups: <18 years 
representing paediatric population, 18–50 years represent 
adult age group and patient >50 years old representing 
older population. The site of lesion was classified on the 
various parts of colon including cecum, ascending colon, 
transverse colon, descending colon, sigmoid colon and 
rectum. The lesions located in the hepatic flexures were 
regarded as ascending colon and those located in splenic 
flexure as descending colon. Finally, all the lesions 
located in cecum, ascending colon and transverse colon 
were regarded as proximal colon, while those located in 
Figure 1: The prevalence of dysplasia in sessile serrated 
adenoma of this study
Figure 2: The prevalence of dysplasia in traditional serrated 
adenoma of this study
Figure 3: The prevalence of dysplasia amongst different age 
groups in this study
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the descending colon, sigmoid colon and rectum were 
regarded as distal colon.
Pathological parameters included type of polyp, and 
presence and degree of dysplasia. Polyps were divided 
into HP, SSA and TSA. Then, dysplastic changes were 
categorised into low-grade and high-grade dysplasia.
For data analysis, Statistical Package for the Social 
Sciences 23 version was used.
Results
This study included 146 biopsies over the duration of 
3 years (2014-2016). 99 (67.8%) were male and 47 (32.2%) 
were female. Mean age was 55.68 ± 13.74 years (range: 
17–83 years). Majority were >50 years 98 (67.1%), 
47 (32.2%) from 18 to 50 years and only one (0.7%) 
patient was under 18 years. HPs were the most common 
type of serrated polyps 108 cases (73.97%) followed by 
TSA 21 (14.38%) and 17 (11.64%) were reported as SSA. 
Hyperplastic polyps and TSAs were found commonly in 
rectum and descending colon, respectively, but SSA was 
common in ascending colon.
Overall dysplasia was seen in 32 of 146 cases (21.9%) and 
114 (78.1%) were without dysplasia. Of these dysplastic, 
biopsies’ only two cases (1.4%) showed high-grade 
dysplasia and rest 30 (20.5%) low-grade dysplasia.
Sessile serrated adenoma showed serrated crypts with 
boot shaped glands in the basal layers, with nuclear 
and architectural atypia [Figure 4]. Traditional serrated 
adenoma showed villous architecture with pencillate cells 
having eosinophilic cytoplasm [Figure 5]. According to 
the type of polyp, dysplasia was found in TSA 8/21 cases 
(46.7%) and SSA 9/17 cases (53.3%).
Discussion
To the best of our knowledge, this study is the first to 
demonstrate the prevalence of dysplasia in serrated/
hyperplastic lesions in Omani population.
In this study, we reviewed 146 colonic biopsies of serrated 
lesion over a period of 3 years (2014–2016).
Our study showed mean age of 55.68 with the range of 
17–83 years. On the other hand, another study showed 
the age mean of 61.6 years. Our study showed male 
predominance in the development of serrated polyps 
(67.8%) which is consistent with other studies.[6,9]
According to our data, HPs have higher prevalence with 
the percentage of 73.97% compared to SSA/polyp and 
TSA which is consistent with reported literature.[10] A 
previous local study showed HPs to have a prevalence of 
31.9% of all polyps.[9]
Regarding the dysplastic changes, our findings showed 
overall percentage of dysplasia to be 21.9%; the result 
was similar to a study conducted in South Korea with 
percentage of 27.4%.[11] Of these, 46.7% of the TSA 
Figure 5: H and E stained section at ×20 magnification showing 
villous architecture of surface with pencillate cells
Figure 4: H and E stained side at ×20 magnification showing 
surface serration, elongation of crypts and few boot-shaped 
glands. Mild dysplasia is noted in basal crypts
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specimens and 53.3% of SSA/P showed dysplastic 
changes. The overall studies suggest that both SSA and 
TSA have malignant potential compared to HP.[12]
We found also that dysplasia detection was higher 
with older age group of >50 years and showed male 
predominance, this was consistent with global studies.[13]
Dysplasia was more common in distal colon compared to 
proximal with P = 0.005. Although, other global studies 
showed higher prevalence of dysplasia in proximal colon.[13]
In summary, we report a high prevalence of HPs compared 
to SSA/polyp and TSA. Age and gender are important risk 
factors not only for developing serrated lesions but also 
increase the possibility of dysplastic changes. These are 
more common in SSA/polyp and traditional serrated. We 
also concluded that our data based on Omani population 
are comparable with international data.
Conclusion
Gastroenterologists should be aware of the emerging 
pattern of serrated lesions of colon and rectum that these 
are now common abnormality that they can face in their 
daily practice compared to past. This result could help guide 
gastroenterologists and endoscopy units in the on-going effort 
to improve detection and resection of precancerous serrated 
lesions. However, multicentre large sample-sized prospective 
studies are needed for further confirmation of our results. In 
addition, we require a better understanding of the molecular 
defects associated with serrated to optimally affect screening 
and prevention of all sporadic colorectal cancer.
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